Hiromachi, Japan

Taichi Manome

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Taichi Manome

Introduction

Taichi Manome is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of genetic engineering through his innovative work. His research has led to the development of a unique plasmid that holds promise for various applications.

Latest Patents

Manome's most recent patent is for a novel plasmid named pSAN 181. This plasmid has a molecular weight of 5 ± 0.2 megadaltons and features single cleavage sites for several restriction endonucleases, including BamHI, PstI, XhoI, and BglII. The positions of these sites are strategically located at 0, approximately 0.85, about 1.15, and around 3.95 megadaltons from the BamHI cleavage site. The plasmid is extracted from the mycelia of microorganisms belonging to the species Streptomyces fulvoviridis, particularly the strain Streptomyces fulvoviridis FERM P-6279. This innovation is particularly useful as a vector for genetic engineering.

Career Highlights

Taichi Manome is currently employed at Sankyo Company, Limited, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, showcasing his dedication to innovation in biotechnology.

Collaborations

Some of his notable coworkers include Mamoru Arai and Toshinori Ohmine. Their collaborative efforts contribute to the ongoing success of their projects and innovations.

Conclusion

Taichi Manome's contributions to the field of genetic engineering through his invention of the plasmid pSAN 181 highlight his role as a significant inventor. His work at Sankyo Company, Limited, along with his collaborations, continues to push the boundaries of scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…